MENU
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  • About Us
  • Blog
  • Series
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  1. Home
  2. Lung Cancer

Lung Cancer– tag –

  • Beginner's series tissue specific tumor

    New Series 1: Lung Cancer—A Calm Overview Before You Jump to Conclusions (Cough, Shortness of Breath, Tests, Staging) | Untangling Cancer Worries: Organ-by-Organ Basics at a Glance

    “My cough won’t go away.” “I get short of breath.” “My health check X-ray showed a shadow.” Once you start searching, it’s easy to get overwhelmed and “My cough won’t go away.” “I get short of breath.” “My health check X-ray showed a sha...
    2026-02-21
  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Sunvozertinib (Zegfrovy) Approved for EGFR Exon20 Insertion-Positive NSCLC

    [FDA Accelerated Approval] New Oral TKI for Advanced NSCLC with EGFR Exon20 Insertions On July 2, 2025, the FDA granted accelerated approval to Sunvozertinib (brand name: Zegfrovy) for the treatment of adult patients with locally advance...
    2025-07-04
  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Datopotamab deruxtecan (Datroway) Receives Accelerated FDA Approval for EGFR-mutated NSCLC

    [FDA Accelerated Approval] Datroway by Daiichi Sankyo approved for EGFR-mutated non-small cell lung cancer (June 23, 2025) On June 23, 2025, the U.S. FDA granted accelerated approval to Datopotamab deruxtecan-dlnk (Datroway) for adults w...
    2025-06-24
1
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語